Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy
NCT00436631 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2015-09-02
Summary
This is a prospective, open-label (no control or blind) study to continue to determine whether the modified Atkins diet reduces seizures, creates ketosis, and is well tolerated in adults (not children) with epilepsy. This study will enroll and manage patients via email, phone, and fax and without dietitian involvement (primary difference from previous studies). It is a 3 month study.
Conditions
Interventions
- BEHAVIORAL
-
Dietary management of seizures
Using the high-fat, low carbohydrate modified Atkins diet - 15 grams per day initially. This is a 3-month study of this diet.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Eric H Kossoff, MD · Johns Hopkins University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2011-02-28
- Completion
- 2011-12-31
Countries
- United States
Study Locations
More Related Trials
-
IF-MCT 16:8: Investigating the Influence of Intermittent Fasting With and Without MCTs in Patients With Drug-resistant Epilepsy
NCT06013761 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy
NCT03183076 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of the Low Glycaemic Index Diet in Adults With Epilepsy
NCT03999827 ·Status: COMPLETED ·Phase: NA
-
Intermittent Fasting in Refractory Epilepsy
NCT02311023 ·Status: TERMINATED ·Phase: PHASE2
-
Ketogenic Diet in Pediatric Intractable Epilepsy
NCT06310954 ·Status: RECRUITING ·Phase: NA
-
Understanding the Mechanism(s) of Action on the Modified Atkins Diet for Epilepsy: Human Brain Tissues
NCT02565966 ·Status: COMPLETED ·Phase: NA
-
Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent.
NCT03031028 ·Status: UNKNOWN ·Phase: PHASE2
-
Modified Atkins Diet Versus Topiramate In Children With Epileptic Spasms Refractory To Hormonal Treatment: A Randomized Open-Label Study
NCT05958160 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Role of Gut Microbiota in Children With Epilepsy Following Ketogenic Diet
NCT05898438 ·Status: UNKNOWN
-
Ketogenic Diet Effects on the Frequency of Non Epileptic Seizures
NCT05219006 ·Status: COMPLETED ·Phase: NA
-
Energy Expenditure and Quality of Life in Epilepsy
NCT04546711 ·Status: WITHDRAWN
-
Comparison Between Efficacy of Daily and Intermittent Low Glycemic Index Therapy Diet
NCT03464487 ·Status: UNKNOWN ·Phase: NA
-
Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
NCT02535091 ·Status: COMPLETED ·Phase: PHASE3
-
Role of the Gut Microbiota in Pediatric Epilepsy
NCT04705298 ·Status: UNKNOWN ·Phase: PHASE4
-
Surgery as a Treatment for Medically Intractable Epilepsy
NCT01273129 ·Status: RECRUITING
-
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
NCT00866775 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.
NCT00236691 ·Status: COMPLETED ·Phase: PHASE2
-
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
NCT01866111 ·Status: COMPLETED ·Phase: PHASE2
-
Duration of Anti-convulsant Therapy for Acute Symptomatic Seizure in Acute Encephalitis Syndrome
NCT03181945 ·Status: UNKNOWN ·Phase: NA
-
LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures
NCT00144872 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures
NCT01397968 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures
NCT00236704 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy
NCT04879433 ·Status: UNKNOWN
-
Microbiome Composition and Biomarker Discovery in Refractory Pediatric Epilepsy
NCT04311242 ·Status: WITHDRAWN
-
Efficacy of Omega-3 as Adjunctive Therapy for Medically Intractable Epilepsy: A Prospective Open-label Pilot Study
NCT02899741 ·Status: UNKNOWN ·Phase: PHASE2